SP
Roles
Therapeutic Areas
Zydus Lifesciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ZyCoV-D | COVID-19 | Approved |
| Saroglitazar | Diabetic Dyslipidemia | Approved |
| Oxemia | Hypertension | Approved |
| Lipaglyn | Type 2 Diabetes | Approved |
| Biosimilar Portfolio | Oncology | Various |
| Generic Pipeline | Multiple | Various |
Leadership Team at Zydus Lifesciences
GN
Ganesh Nayak
Executive Director
DV
Dr. Vishal Gupta
Executive Director
TA
Tarun Arora
Chief Financial Officer